AstraZeneca, Britain's most valuable public company and responsible for one of the Covid vaccines, reportedly wants to move ...

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...

While London South East do their best to maintain the high quality of the information displayed on this site, we cannot ...

It was already a bad enough week for the Prime Minister Sir Keir Starmer and the Chancellor Rachel Reeves, what with the ...

Indian pharmaceutical industry defends Covid-19 vaccines amid concerns, emphasizing global standards, safety, and efficacy to ...

The yields on UK ten year bonds rose sharply on Wednesday as Keir Starmer failed to guarantee the job of chancellor Rachel ...

Reports are circulating that AstraZeneca shares could be moving off the London exchange with its CEO favouring a US market ...

DelveInsight’s Metastatic Prostate Cancer Pipeline report depicts a robust space with 80+ active players working to develop ...

London's blue-chip stock index edged higher and the midcap index fell on Wednesday as investors assessed a mixed bag of corporate news, including a media report that AstraZeneca is moving its listing ...

During a live event, Heather L. McArthur, MD, MPH, discussed the TAILORx trial in node-negative hormone ...

London's IPO drought just hit a new lowand it's getting harder to ignore. AstraZeneca (NASDAQ:AZN), the UK's largest listed ...

AstraZeneca boss Sir Pascal Soriot (pictured) is thought to be mulling shifting its listing to New York due to growing ...